Utah Medical Products (UTMD) Accumulated Depreciation & Amortization (2011 - 2025)

Utah Medical Products has reported Accumulated Depreciation & Amortization for 15 years, with the latest figure at $25.3 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 5.91% year-over-year to $25.3 million; the trailing twelve-month figure through Dec 2025 stood at $25.3 million (up 5.91% YoY), and the FY2025 full-year result was $25.3 million, up 5.91% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $25.3 million, up from $23.9 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $25.3 million in Q4 2025, with the low at $22.8 million in Q4 2021.
• Average Accumulated Depreciation & Amortization over 5 years is $23.7 million, with a median of $23.7 million recorded in 2023.
• Year-over-year, Accumulated Depreciation & Amortization gained 0.62% in 2022 and rose 5.91% in 2025.
• Tracing UTMD's Accumulated Depreciation & Amortization over 5 years: stood at $22.8 million in 2021, then climbed by 0.62% to $22.9 million in 2022, then climbed by 3.39% to $23.7 million in 2023, then climbed by 0.86% to $23.9 million in 2024, then climbed by 5.91% to $25.3 million in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at $25.3 million (Q4 2025), $23.9 million (Q4 2024), and $23.7 million (Q4 2023), per Business Quant data.

Peer Comparison